Purna Bahadur POUDEL

Dr. Purna Bahadur POUDEL

BMB, Washington University in St. Louis School of Medicine, St Louis, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BTBijaya Bahadur Thapa
Bijaya Bahadur Thapa
CHChen Huo
Chen Huo
Rabin BudhathokiRabin Budhathoki
Rabin Budhathoki
PCPratiksha Chaudhary
Pratiksha Chaudhary
SJSoniya Joshi
Soniya Joshi
Jae Kyung SohngJae Kyung Sohng
Jae Kyung Sohng
Streptomyces are well-known for producing bioactive secondary metabolites, with numerous antimicrobials essential to fight against infectious diseases. Globally, multidrug-resistant (MDR) microorganisms significantly challenge human and veterinary diseases. To tackle this issue, there is an urgent need for alternative antimicrobials. In the search for potent agents, we have isolated four Streptomyces species PC1, BT1, BT2, and BT3 from soils collected from various geographical regions of the Himalayan country Nepal, which were then identified based on morphology and 16S rRNA gene sequencing. The relationship of soil microbes with different Streptomyces species has been shown in phylogenetic trees. Antimicrobial potency of isolates was carried out against Staphylococcus aureus American Type Culture Collection (ATCC) 43300, Shigella sonnei ATCC 25931, Salmonella typhi ATCC 14028, Klebsiella pneumoniae ATCC 700603, and Escherichia coli ATCC 25922. Among them, Streptomyces species PC1 showed the highest zone of inhibition against tested pathogens. Furthermore, ethyl acetate extracts of shake flask fermentation of these Streptomyces strains were subjected to liquid chromatography-tandem mass spectrometric (LC-MS/MS) analysis for their metabolic comparison and Global Natural Products Social Molecular Networking (GNPS) web-based molecular networking. We found very similar metabolite composition in four strains, despite their geographical variation. In addition, we have identified thirty-seven metabolites using LC-MS/MS analysis, with the majority belonging to the diketopiperazine class. Among these, to the best of our knowledge, four metabolites, namely cyclo-(Ile-Ser), 2-n-hexyl-5-n-propylresorcinol, 3-[(6-methylpyrazin-2-yl) methyl]-1H-indole, and cyclo-(d-Leu-l-Trp), were detected for the first time in Streptomyces species. Besides these, other 23 metabolites including surfactin B, surfactin C, surfactin D, and valinomycin were identified with the help of GNPS-based molecular networking.

29 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
PPPurna Bahadur POUDEL
Purna Bahadur POUDEL
Dipesh DhakalDipesh Dhakal
Dipesh Dhakal
Rubin Thapa MagarRubin Thapa Magar
Rubin Thapa Magar
Jae Kyung SohngJae Kyung Sohng
Jae Kyung Sohng
Anthraquinone and its derivatives show remarkable biological properties such as anticancer, antibacterial, antifungal, and antiviral activities. Hence, anthraquinones derivatives have been of prime interest in drug development. This study developed a recombinant Escherichia coli strain to modify chrysazin to chrysazin-8-O-α-l-rhamnoside (CR) and chrysazin-8-O-α-l-2′-O-methylrhamnoside (CRM) using rhamnosyl transferase and sugar-O-methyltransferase. Biosynthesized CR and CRM were structurally characterized using HPLC, high-resolution mass spectrometry, and various nuclear magnetic resonance analyses. Antimicrobial effects of chrysazin, CR, and CRM against 18 superbugs, including 14 Gram-positive and 4 Gram-negative pathogens, were investigated. CR and CRM exhibited antimicrobial activities against nine pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) in a disk diffusion assay at a concentration of 40 µg per disk. There were MIC and MBC values of 7.81–31.25 µg/mL for CR and CRM against methicillin-sensitive S. aureus CCARM 0205 (MSSA) for which the parent chrysazin is more than >1000 µg/mL. Furthermore, the anti-proliferative properties of chrysazin, CR, and CRM were assayed using AGS, Huh7, HL60, and HaCaT cell lines. CR and CRM showed higher antibacterial and anticancer properties than chrysazin.

5 December 2019 in Microbiology Resource Announcements
Verified
Journal Article
Open access
PDF file
Dipesh DhakalDipesh Dhakal
Dipesh Dhakal
Vijay RayamajhiVijay Rayamajhi
Vijay Rayamajhi
HNHue Thi Nguyen
Hue Thi Nguyen
PPPurna Bahadur POUDEL
Purna Bahadur POUDEL
Jae Kyung SohngJae Kyung Sohng
Jae Kyung Sohng
Nocardia sp. strain CS682 is a rare actinobacterium with a promising ability to produce secondary metabolites such as nargenicin A1 (an effective antibacterial compound) and IBR-3 (a UV-protectant molecule). Here, we report the complete genome sequence of Nocardia sp. CS682, obtained by PacBio sequencing as a single contig with 8,919,230 bp (GC content, 63.3%).

5 May 2023 in Journal of Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
PPPurna Bahadur POUDEL
Purna Bahadur POUDEL
RMRubin Thapa Magar
Rubin Thapa Magar
ABAdzemye Fovennso Bridget
Adzemye Fovennso Bridget
Jae Kyung SohngJae Kyung Sohng
Jae Kyung Sohng
Purna Bahadur Poudel, Rubin Thapa Magar , Adzemye Fovennso Bridget , and Jae Kyung Sohng. J. Microbiol. Biotechnol. 2023;33:949-54. https://doi.org/10.4014/jmb.2303.03008

21 January 2023 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
RMRubin Thapa Magar
Rubin Thapa Magar
VPVan Thuy Thi Pham
Van Thuy Thi Pham
PPPurna Bahadur POUDEL
Purna Bahadur POUDEL
HNHue Thi Nguyen
Hue Thi Nguyen
ABAdzemye Fovennso Bridget
Adzemye Fovennso Bridget
Jae Kyung SohngJae Kyung Sohng
Jae Kyung Sohng

Verified
Journal Article
Open access
PDF file
PPPurna Bahadur POUDEL
Purna Bahadur POUDEL
Dipesh DhakalDipesh Dhakal
Dipesh Dhakal
Rubin Thapa MagarRubin Thapa Magar
Rubin Thapa Magar
NPNiranjan Parajuli
Niranjan Parajuli
Jae Kyung SohngJae Kyung Sohng
Jae Kyung Sohng
The identification of specialized metabolites isolated from microorganisms is urgently needed to determine their roles in treating cancer and controlling multidrug-resistant pathogens. Naphthoquinones act as anticancer agents in various types of cancers, but some toxicity indicators have been limited in their appropriate application. In this context, new isofuranonaphthoquinones (ifnq) that are less toxic to humans could be promising lead compounds for developing anticancer drugs. The aim of this study is to identify and characterize novel furanonaphthoquinones (fnqs) from Nocardia sp. CS682 and to evaluate their potential therapeutic applications. Analysis of the genome of Nocardia sp. CS682 revealed the presence of a furanonaphthoquinone (fnq) gene cluster, which displays a similar genetic organization and high nucleotide sequence identity to the ifnq gene cluster from Streptomyces sp. RI-77, a producer of the naphthoquinones JBIR-76 and JBIR-77. In this study, the overexpression of the Streptomyces antibiotic regulatory protein (SARP) in Nocardia sp. CS682DR (nargenicin gene-deleted mutant) explicitly produced new fnqs, namely, NOC-IBR1 and NOC-IBR2. Subsequently, the role of the SARP regulator was confirmed by gene inactivation using CRISPR-Cas9 and complementation studies. Furthermore, antioxidant, antimicrobial, and cytotoxicity assays were performed for the isolated compounds, and it was found that NOC-IBR2 exhibited superior activities to NOC-IBR1. In addition, a flexible methyltransferase substrate, ThnM3, was found to be involved in terminal methylation of NOC-IBR1, which was confirmed by in vitro enzyme assays. Thus, this study supports the importance of genome mining and genome editing approaches for exploring new specialized metabolites in a rare actinomycete called Nocardia.